Contents
Contents
In the Recovery Centers of America fraud case, the company agreed to pay $2 million to resolve allegations of inadequate drug and alcohol treatment billed to government programs and mishandled controlled substances. The Justice Department announced the agreement on December 10, 2025. A former outcomes supervisor at corporate headquarters brought the whistleblower case.
We see a particularly ugly allegation here: people sought help for addiction, while the government says their treatment provider billed for care it failed to adequately deliver. The patient needed the treatment. The company still sent the bill, according to the government’s allegations.
Recovery Centers of America agreed to pay $1 million to resolve allegations under the False Claims Act that it billed the Federal Employees Health Benefits Program and Medicaid for care without providing and documenting the required treatment. The treatment-billing allegations concerned certain facilities during 2017 through 2019.
The company named in the case was TRC-OC, trading as Recovery Centers of America Holdings, LLC.
The government put delivery and documentation together. That matters to a counselor who knows what happened in a session, an outcomes worker reviewing treatment records, or a biller whose work begins after the clinical encounter. Each may see a different part of the same claim. We connect those accounts to the service the payer was charged for.
Behavioral health payment follows the service: an individual encounter, a group session, a program day or a treatment bundle. Those units ask different things of the staff and the documentation. A patient’s presence at a facility says less than a treatment record identifying the work performed, the person who performed it and the service billed. That is why we start with the actual claim and its payer, rather than treating every visit to an addiction center as the same transaction.
The company agreed to pay a separate $1 million to resolve Controlled Substances Act allegations arising from Drug Enforcement Administration audits and investigations at its Pennsylvania and Maryland facilities between 2019 and 2024. The government alleged unlawful dispensing, controlled substances missing from the company’s records, and failures to meet other recordkeeping requirements.
The government’s announcement describes controls intended to prevent controlled substances from being diverted to illegal uses. A dispensing event and the record of that event are therefore central to this part of the case.
The Drug Enforcement Administration conducted the facility audits and investigations behind the controlled-substance allegations in the Recovery Centers of America case. The resolution also involved the U.S. Attorney’s Office for the Eastern District of Pennsylvania, the Office of Personnel Management Office of Inspector General, and the Department of Health and Human Services Office of Inspector General.
The government described a coordinated effort among those offices. The agencies’ roles reflect the different parts of the case: medication controls and claims to government health care programs.
Treatment records and billing claims are where we start in an addiction-treatment fraud case, with you explaining the care behind them. We work with you to understand what your own job lets you see and how it bears on the government payments.
In Recovery Centers of America’s case, the whistleblower was a former outcomes supervisor at the company’s corporate headquarters in King of Prussia, Pennsylvania. The settlement resolved that employee’s qui tam case. The role gives an outcomes or quality worker a concrete reason to recognize themselves in this case: the person who brought it worked at headquarters.
We compare the services scheduled with attendance, staff assignments, clinical notes and the claims submitted for that work. When the concern involves records completed later, the sequence matters too: what staff knew at the time, what they recorded then, and what changed afterward. The people who delivered the care can explain discrepancies a billing entry leaves invisible.
For a concern involving controlled substances, we would examine the dispensing event and the company’s record of it, tied to the facility involved. We would also distinguish what a worker saw at the time from what a later audit identified. These are different views into the operation, and knowing which one you have helps us assess the case with you.
In the separate case against The Journey to Hope Health and Healing, the government’s complaint alleged that counselors created backdated treatment plans without seeing the patients, illustrating why a record’s creation date matters alongside its contents.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. The agreement provided for the former outcomes supervisor to receive a share of the settlement.
If your work in outcomes, counseling, billing or medication handling shows a gap between the care and the records, speak to one of our Whistleblower Experts. We work beside you to build your strongest addiction-treatment fraud whistleblower case and bring in addiction-treatment fraud whistleblower lawyers who understand the payment and clinical issues. From the first account of what happened through the case, we stay on your side.